DB

Daniel Brennan

#675 out of 1699 analysts
TD Cowen
Automatically Tracked
Tracking: 0 Updated: Jun 15 at 01:54 PM

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
2.39%
Gain
Monthly
0.7%
Yearly
8.75%
Drawdown
40.77%
$115,982.28
Equity
Holdings
$0
Cash
$115,982.28
Investment
$0
$15,982.28
Profit
Realized
$15,982.28
Unrealized
$0
Dividends
$0
$115,982.28
Cash
Deposits
$100,000
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
0%
Profit
$0
Win %
0%
This Week
Compared To Last Week
Gain
-10.97%
Profit
-$14,287.67
Win %
0%
This Month
Compared to last month
Gain
-10.97%
Profit
-$14,287.67
Win %
0%
This Year
Compared to last year
Gain
-21.14%
Profit
-$31,096.7
Win %
0%
Pacific Biosciences of California, Inc. logo
PACB Pacific Biosciences of California, Inc.
+$27,868.07
Standard Biotools Inc. logo
LAB Standard Biotools Inc.
-$11,885.79
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
6
Longs Won
2/6 33%
Profit Factor
2.18
Profitability
Shorts Won
0/0 0%
Standard Deviation
$11,428.39
Average Win
$14,785.1
Best Trade
(Jul 26) $24,681.99
Sharpe Ratio
-9.09
Average Loss
-$3,396.98
Worst Trade
(Jul 25) -$6,710.37
Z-Score
-0.18 (14.03%)
Commissions
$0
Avg. Trade Length
2m 3w 1d
Expectancy
$2,663.71
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% <0.01% 0.07% 0.45% 1.63% 4.44% 10.07% 20.13% 36.69% 62.28%
Consecutive Losing Trades 34 31 27 24 20 17 14 10 7 3
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV